Skip to main content
. 2012 Sep-Dec;16(3):325–329. doi: 10.4103/0973-029X.102476

Table 2.

Comparison of ViziLite™ and toluidine blue positivity in precancer

graphic file with name JOMFP-16-325-g005.jpg